These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 15690335)
41. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Dejmek A; Hjerpe A Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331 [TBL] [Abstract][Full Text] [Related]
42. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain. Yang GC Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641 [TBL] [Abstract][Full Text] [Related]
43. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology. Canessa PA; Franceschini MC; Ferro P; Battolla E; Dessanti P; Manta C; Sivori M; Pezzi R; Fontana V; Fedeli F; Pistillo MP; Roncella S Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166 [TBL] [Abstract][Full Text] [Related]
45. An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers. Miller LJ; Holmes IM; Lew M Arch Pathol Lab Med; 2024 Apr; 148(4):409-418. PubMed ID: 37622452 [TBL] [Abstract][Full Text] [Related]
46. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268 [TBL] [Abstract][Full Text] [Related]
47. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy. Evans DA; Thornthwaite JT; Ng AB; Sugarbaker EV Anal Quant Cytol; 1983 Mar; 5(1):19-27. PubMed ID: 6846965 [TBL] [Abstract][Full Text] [Related]
48. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma. Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231 [TBL] [Abstract][Full Text] [Related]
49. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology. Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174 [TBL] [Abstract][Full Text] [Related]
50. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions. Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939 [TBL] [Abstract][Full Text] [Related]
51. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution]. Vignale L; Galli G; Rossi PC; Parentini GC Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of membranous staining of mesothelioma. King JA; Tucker JA Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721 [TBL] [Abstract][Full Text] [Related]
53. [Utility of morphometry and nucleolar organizer regions count in the differentiation of reactive and malignant mesothelial cells in pleural effusions]. Colecchia M; Agnelli T; Caronni E; Leopardi O Pathologica; 1991; 83(1083):89-97. PubMed ID: 1866205 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks. Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664 [TBL] [Abstract][Full Text] [Related]
56. [Clinical masks of pleural mesothelioma]. Shchennikov EL; Rybkis AI Ter Arkh; 1993; 65(4):86-8. PubMed ID: 8059416 [No Abstract] [Full Text] [Related]
57. Accuracy and reproducibility of pleural effusion cytology. Fassina A; Fedeli U; Corradin M; Da Frè M; Fabbris L Leg Med (Tokyo); 2008 Jan; 10(1):20-5. PubMed ID: 17702624 [TBL] [Abstract][Full Text] [Related]
58. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624 [TBL] [Abstract][Full Text] [Related]
59. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions. Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633 [TBL] [Abstract][Full Text] [Related]
60. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]